The post The Red Alert Time Zone appeared first on TradingMarkets.com.

In terms of the pumping activity, the campaign started on April 15 when the first emails from the aforementioned newsletters hit the investors' inboxes and from the very start it looked like the whole thing will turn into a spectacular failure. The ticker started going South at a rapid speed and by the end of April it was pretty close to its 52-week low. A couple of days later, it reached it causing quite a lot of grumpy faces among investors.

And just as everyone thought that the stock is done for, GMEC managed to recover. And what a recovery? It began on May 3 and after a relatively slow start it absolutely skyrocketed. By May 15 the price had increased by a whopping 583%. This was followed by two days in the red, but yesterday, it gained some ground back up and right now, about an hour into the trading session, it's going strong. All in all, quite the epic run, we would say.

GMEC also managed to publish their quarterly report for the period before March 31 yesterday and when we saw a new filing, we thought that it was the reason for the 20% gains from the latest trading session. That's not strictly the case, though. Here are the figures:

• cash: $298 thousand
• current assets: $804 thousand
• current liabilities: $1.4 million
• revenue: $371 thousand
• net loss: $306 thousand

More worryingly, when you take just a quick look through the statement and compare it with the one from last year, you will see that the current financials look a lot worse. GMEC say, however, that there is a silver lining.

They seem to rely on the fact that they have stopped some of their unprofitable subsidiaries, and they have high hopes that this will make the years to come a lot brighter. While that might turn out to be correct, we can't really be sure if it will happen and we won't be until we see the next financial statements. Unfortunately, we'll need to wait for quite a bit longer until we receive them.

In the meantime, we would like to discuss some things that turn GMEC into a not-so-attractive investment option.

Share issuance is the first one. They said in a press release back on April 19 that they are paying off some of the debt in cash so that they can avoid new shares being issued which would dilute the shareholders' investment. If you read through our article from April 22 you will see that we have included it in our report and, of course we said that taking care of your shareholders is an admirable thing to do. They don't seem to issue press releases when they convert $75 thousand worth of debt into a whopping 5.1 million common shares, though. According to the latest 10-Q, that's exactly what they did.

The second thing that we would like to turn our attention to is GMEC's promotional history. The first email that we managed to intercept about them is dated October 14, 2012 and since then the number has grown to more that 140. Not enough space in our inbox, however is the least of our worries. When you compare the stock price back then with the one right now, you will see that even after the impressive run from the last few weeks, GMEC's shares are now around 53% cheaper.

This just goes to show that when a company relies on nothing more than artificial hype created by bombastic press releases and paid promoters, things usually don't end well. It's up to you to choose wisely and take good care before jumping in on excitement alone.

The company's stock has little movements which are almost unnoticeable for the past month. The last two trading sessions started at higher prices than the previous days, but yesterday they finished below what they opened at.

Today their price has already gained 15% with a considerable volume of nearly 6 million shares traded in just 1 hour from market open. The gain made their stock price jump from $0.0118 to $0.0130 with a total trade value of $77 thousand. However, where will it go from here?

As most recently they submitted a quarterly report under the alternative reporting standard in the OTC Markets we can take a look at how things have been developing for them, financial-wise, from the beginning of the year until March 31. The numbers of prime interest are listed below.

cash: $374
total assets: $39 thousand ($32 thousand in mining claims)
current liabilities: $27 thousand
total liabilities: $204 thousand
revenue: $0
net loss: $67 thousand[BANNER]

The report also contains information about the misteryous private investment group that is going to provide them with a $1 million loan. Again this investment group is left unnamed. As we noted in our previous article about TRLR they are in the OTC Markets Pink Sheet Tier and are not a SEC filer. This means that they are not obliged to give this information if they are not inclined to do so.

All we can say about their stock for now is that it can literally go anywhere as it is constantly being pumped with no actual results so far. Another thing that you might want to take into consideration is the fact that most of the serious mining companies and even some of the scams out there file reports with the SEC. We can't point out the reason for TRLR's decision not to do so, but it seems shady.

All in all TRLR are a risky investment choice, so be sure to do your due diligence and weigh out the risks before you make up your mind.

NNVC is a development-stage company that trying to create a special purpose nanomaterials for viral therapy. They have targeted a wide range of viral diseases in the likes of swine flu, bird flu, seasonal Influenza, HIV, Hepatitis C, and the Ebola virus.

Despite being relatively high priced, the ticker has seen its fair share of volatility. In late February it dropped to $0.32 just to double in value a week later. Since then the stock has been fluctuating a lot but never reaching such drastic movements.[BANNER]

On the financial side of things NNVC is leagues ahead of most of the other pennystock development-stage companies. In their latest quarterly report for the period ending March 31 they disclosed :

• $15 million cash
• $16.9 million total current assets
• $4 million total current assets
• $3.6 million net loss

The company is not generating any revenues but that is to be expected. Having secured such a vast amount of funds due to private placements if the company's stock, their next goal is to meet the FDA's requirements for IND (investigational new drug).

One thing that investors should keep in mind is the new pump campaign that began yesterday. Some of the affiliates of Blue Wave Advisors - BeaconEquity, InvestorSoup and PennyStockFinder to be precise, send a round of alert emails regarding NNVC. LuckyStockPicks and PennyStockShark also decided to join in on the effort. All of the promoters apparently received no compensation for the campaign which means they will find their profit in a more subtle way.